The notebook Magnus Helle had given Voss was small—no larger than a breviary, fitting easily into the inside pocket of his coat—but its weight was immense. Voss carried it back to the guesthouse through the clearing storm, the stars emerging overhead like pins of light pushed through a dark fabric, and when he reached his room he locked the door, drew the curtains, and began to read.
What Helle had documented over five years of hiding was nothing less than a complete anatomy of a corporate conspiracy. The notebook contained dates, names, internal memoranda, meeting minutes, and excerpts from email correspondence that Helle had either intercepted or been copied on before his disappearance. The earliest entries dated back to February 2018, three months before Cardizine received its European marketing authorization, when the Phase III trial data had first revealed the anomalous response in patients with the CYP2C9 variant.
According to the documents, a meeting had been held on February 14, 2018, at OmniCure's headquarters in Kvelborg. The attendees included the chief executive officer, the head of regulatory affairs, the lead clinical investigator, and a senior vice president named Sebastian Rask, who served as OmniCure's chief legal officer. The meeting had been called specifically to discuss the bleeding signal detected in the genetic subgroup. The minutes, which Helle had obtained from a source he identified only as "J.L.," recorded Rask's assessment in chillingly precise terms:
"The commercial impact of a contraindication for patients with the CYP2C9 variant would be catastrophic. The variant is present in approximately fourteen percent of the Northern European population. Requiring genetic testing before prescription would reduce the addressable market by at least that amount and would likely trigger additional regulatory scrutiny that could delay approval indefinitely. It is my recommendation that the subgroup analysis be excluded from the final submission and that we proceed with the existing data package. The statistical methods for excluding subgroup analyses from primary endpoints are well established and defensible."
The minutes showed that no one at the meeting had objected to Rask's recommendation. The lead clinical investigator had noted that the bleeding risk was "potentially serious" but had agreed that it could be managed through post-marketing surveillance. The head of regulatory affairs had suggested burying the data in a supplementary appendix rather than excluding it entirely, as a hedge against future liability. The CEO had approved the approach with a single word: "Proceed."
Voss read the passage three times, his hands steady but his mind racing. The decision to conceal the bleeding risk had been made at the highest levels of the company, with full knowledge of the potential consequences. It was not an oversight, not an accident, not a bureaucratic error. It was a calculated choice, made by people who had weighed the value of human lives against the value of corporate profits and had chosen the latter.
But the notebook contained more than just evidence of the original cover-up. As Voss read further, he discovered that Helle had documented a second, more sinister phase of the conspiracy—one that had begun approximately two years after Cardizine's approval, when the post-marketing surveillance data had begun to show an alarming number of deaths among elderly patients.
According to Helle's notes, OmniCure's internal safety monitoring system had flagged thirty-seven deaths by early 2020 that showed temporal associations with Cardizine prescriptions. The company's pharmacovigilance department had conducted an internal review and had concluded that the deaths were "consistent with the known anticoagulant effect in CYP2C9 variant carriers." But instead of reporting these findings to the regulatory authorities, OmniCure had taken a different approach.
In March 2020, Rask had convened a meeting with a select group of executives and clinicians to discuss what he called "proactive evidence management." The minutes of that meeting, which Helle had obtained through a source in OmniCure's legal department, showed that Rask had proposed a systematic program to "contextualize" the deaths by ensuring that they occurred in populations where mortality was expected and where autopsies were unlikely to detect anomalies.
The program, which Rask had code-named "Protocol Cleansweep," involved identifying assisted living facilities with high concentrations of elderly patients, placing OmniCure-affiliated physicians in those facilities, and prescribing Cardizine to patients who were statistically likely to die within the near future regardless of the drug's effects. The deaths would be certified as natural cardiac events, the bodies would be cremated before toxicological analysis could be performed, and the data would be entered into the post-marketing surveillance system as "expected mortality in elderly populations with pre-existing cardiovascular disease."
Torben Malling, the physician who had been involved in the original clinical trials, had been recruited to implement Protocol Cleansweep at Solberg facilities across northern Valdoria. According to Helle's notes, Malling had been compensated handsomely for his participation—payments funneled through a series of shell companies and offshore accounts that made them virtually impossible to trace. The payments totaled over two million euros over three years, a sum that Helle had documented with bank records and wire transfer confirmations.
Voss set down the notebook and stared at the wall of his room. His mind, trained by years of monastic discipline to process complex information in silence, was working through the implications with the cold precision of a logical proof. Protocol Cleansweep was not just a cover-up. It was an active program of murder, designed to eliminate the evidence of Cardizine's dangers by killing the patients who might expose them. The seven deaths Voss had identified were not anomalies. They were deliberate acts, carried out according to a plan that had been approved at the highest levels of one of Valdoria's largest corporations.
But the evidence Voss had gathered—the notebook, the research data, the prescription records, the statistical analysis—was not sufficient for a criminal conviction. That was the problem that occupied his thoughts as the hours passed and the night deepened toward dawn. The evidence proved that OmniCure had known about the bleeding risk. It proved that Protocol Cleansweep existed. It proved that Torben Malling had been paid to prescribe Cardizine to elderly patients. But it did not prove that any specific death had been caused by the drug rather than by the underlying cardiovascular disease. Without that proof, a prosecutor could not establish causation. And without causation, there could be no conviction for murder.
The perfect crime, Voss realized, had been designed to exploit a fundamental asymmetry between scientific knowledge and legal proof. OmniCure's executives had understood that modern forensic toxicology could not detect the heparin analog after death because the compound degraded within seventy-two hours. They had understood that the statistical probability of the deaths occurring by chance was not admissible as evidence of causation in Valdorian courts. They had built a killing machine that was invisible to the instruments of modern justice, protected by the very sophistication of the science that should have exposed it.
Voss closed the notebook and placed it on the nightstand beside his bed. Outside, the first pale light of dawn was beginning to touch the horizon. He had not slept, but he did not feel tired. His mind was still working, turning over the problem from different angles, searching for a solution that would not come through conventional means.
And then, as the light grew stronger and the birds began to sing in the wind-bent trees outside his window, Voss remembered something. He remembered the monastery library at Andenes, where he had spent countless hours studying the works of the medieval Scholastics—men like Thomas Aquinas and Duns Scotus and William of Ockham, who had developed methods of logical analysis that predated modern science by centuries. The Scholastics had not needed forensic laboratories or DNA sequencing to establish truth. They had used reason alone, constructing logical proofs that could demonstrate the necessity of a conclusion from established premises.
The Valdorian legal system, Voss knew, was built on a foundation that predated the modern era. Beneath the layers of statutory law and regulatory procedure, there remained a body of ancient legal principles that had never been formally abolished—remnants of the medieval canon law that had governed Valdoria before the Reformation. One of those principles was the "Rule of Inevitable Inference," which held that a fact could be established by logical demonstration if no other explanation was possible. The rule had fallen into disuse over the centuries, replaced by modern evidentiary standards that emphasized empirical proof. But it had never been formally repealed. It was still there, buried in the legal codes like a fossil waiting to be unearthed.
If Voss could construct a logical proof demonstrating that the seven deaths could not have occurred naturally—that they were, in the language of the Scholastics, "necessary" rather than "accidental"—then he might be able to establish causation without forensic evidence. The proof would not rely on toxicology or DNA or any of the other tools that OmniCure had designed its crimes to evade. It would rely on logic alone, the same logic that had been used by medieval inquisitors to establish truth in an age before science.
He sat down at the small desk in his room, opened a fresh page in his notebook, and began to write.
—
In Kvelborg, Klara Myhre was preparing for war.
The article she had written based on the anonymous source's information had been published that morning on Aftenposten's front page, under the headline: "Seven Deaths, One Drug: The Suspicious Pattern at Solberg Assisted Living." The article was cautious, carefully worded to avoid direct accusations while presenting the statistical evidence that Klara had verified through her own research. It did not mention OmniCure by name except in passing, and it did not allege criminal conduct. But it raised questions that demanded answers, and it included a sidebar with the names of all seven deceased patients, their ages, and the dates of their deaths.
The response had been immediate and ferocious.
Within two hours of publication, OmniCure's legal department had issued a statement denouncing the article as "irresponsible speculation based on statistical manipulation." The statement cited the company's "unwavering commitment to patient safety" and announced that OmniCure would be "pursuing all available legal remedies against those who have made false and defamatory allegations." Sebastian Rask, the chief legal officer, had given an interview to the Valdorian Broadcasting Corporation in which he described the article as "journalistic malpractice of the highest order" and hinted at a defamation lawsuit that could "bankrupt any publication foolish enough to print such nonsense."
At the same time, Solberg Assisted Living had issued its own statement, defending Dr. Torben Malling as "a physician of impeccable credentials and the highest ethical standards." The statement noted that all seven patients had been elderly, with significant pre-existing conditions, and that their deaths had been certified as natural by multiple medical professionals. The implication was clear: Klara Myhre was a sensation-seeking journalist who was exploiting the deaths of vulnerable elderly people to sell newspapers.
Klara had expected this response. What she had not expected was the speed and coordination of the counterattack. Within hours, anonymous sources began contacting other news outlets with information designed to discredit her. A story appeared in Kapital, the financial daily where Klara had once worked, suggesting that she had been dismissed from her previous position for "ethical violations"—a charge that was entirely false but difficult to refute without revealing confidential employment records. A blog post by a self-described "media ethics watchdog" accused her of fabricating sources and manipulating data. By midday, the hashtag #KlaraMyhreHoax was trending on Valdorian social media.
She sat in her editor's office, the door closed, the blinds drawn against the gray afternoon light. Her editor, a veteran journalist named Birger Solheim who had survived three regime changes and two attempts to shut down the paper, was reading the OmniCure legal threat with the expression of a man who had seen this kind of thing before and was not impressed.
"They're good," Solheim said. "Very good. The defamation threat is standard, but the personal attacks are a nice touch. Someone's done their homework on you."
"They're trying to make me the story instead of the deaths."
"Of course they are. That's what corporations do when they can't defend the facts. They attack the messenger." He set down the letter and looked at Klara over the tops of his glasses. "Do you have more? You said your source provided additional documentation."
"Prescription records for Torben Malling. And I've been trying to reach a pharmacologist named Linnea Dahl, who worked on the original Cardizine trials before she was discredited. She might have information about what OmniCure knew and when."
"Dahl." Solheim's expression shifted. "I remember that case. She accused OmniCure of suppressing data, but she couldn't prove it, and they destroyed her. If you can find her and she'll talk, that would be significant. But she's been off the grid for years."
"I know where she is. She's working at a bar in the harbor district called The Rusted Anchor. I found her through corporate registry records."
Solheim was silent for a moment, considering. Then he nodded slowly. "Go talk to her. But be careful. If OmniCure is willing to attack you publicly on the first day, they're going to escalate. Keep your notes secure. Don't use your work phone for anything sensitive. And Klara—don't go anywhere alone if you can help it. I've seen corporations do worse things than ruin a journalist's reputation."
—
The proof took Voss three days to construct.
He worked in the guesthouse room, leaving only to eat and to walk along the shoreline in the gray light of the autumn afternoons. The work required him to think in ways he had not thought since his years at the monastery, drawing on the Scholastic methods he had studied as a young novice. He had to translate the messy reality of medical data into the clean language of logical propositions, reducing each element of the case to a statement that could be either affirmed or denied, and then building those statements into a chain of reasoning that would compel a single, unavoidable conclusion.
The structure of the proof was based on the Scholastic method of disputation, which began with a question—"Whether the seven deaths were caused by Cardizine administration"—and proceeded through a series of objections and responses before arriving at a determination. Each objection represented a possible alternative explanation for the deaths: natural disease progression, coincidence, statistical clustering, confounding factors. Each response demonstrated why the alternative explanation was logically impossible or so improbable as to be rationally excluded.
The key to the proof was the concept of "necessary connection," which the Scholastics had used to distinguish between events that were merely associated in time and events that were causally linked. Voss argued that the temporal proximity between Cardizine administration and each death—always within twenty-one to twenty-eight days—was too consistent to be coincidental. The genetic variant that made Cardizine lethal was present in a predictable percentage of the Northern Valdorian population, and the clustering of deaths among patients who had been prescribed the drug by a single physician with knowledge of the variant was too specific to be accidental. The payments to Torben Malling, documented in Helle's notebook, established motive and intent. The destruction of blood samples, the cremation of bodies, the systematic isolation of each death into a separate administrative silo—all of these elements formed a pattern that could only be explained by deliberate design.
By the end of the third day, Voss had filled thirty pages with dense logical notation. The proof was complete, but it was written in a form that no modern court would recognize—a form that had last been used in the ecclesiastical courts of medieval Europe. Voss knew that he would need to translate it into language that a modern judge could accept. But he also knew that the underlying logic was sound. It was not science, in the modern sense, but it was truth, in the ancient sense—a truth that could be demonstrated through reason alone.
He copied the proof onto a fresh set of pages, sealed them in an envelope, and addressed it to the Valdorian Supreme Court in Kvelborg. Then he wrote a second copy and addressed it to Klara Myhre at Aftenposten. The third copy, he kept for himself.
As he walked to the post office in Åkvåg to mail the envelopes, Voss thought about the journey that had brought him to this point. He had started with a burial benefit claim and a statistical anomaly. He had ended with a logical proof that could, if accepted, bring down one of the most powerful corporations in Valdoria. The path between those two points had been long and strange, winding through monastery libraries and harbor bars, through storage units and dying men's notebooks, through data that had been hidden and truths that had been buried. But it had led him here, to this moment, with three envelopes in his hand and a question that only the courts could answer.
He mailed the envelopes and walked back to the guesthouse, where he packed his belongings and prepared to return to the mainland. The ferry would leave in the morning. In Kvelborg, two hundred kilometers to the south, the rain was still falling, and the city was waiting for him like a question mark at the end of a sentence he had not yet finished writing.
—
The letter arrived at Sebastian Rask's office on a Thursday morning, delivered by courier in a plain white envelope with no return address.
Rask's secretary brought it to him during a meeting with OmniCure's public relations team, who were discussing the ongoing fallout from the Aftenposten article. The secretary knew better than to interrupt, but the envelope was marked "URGENT — LEGAL MATTER" in handwriting that looked as though it had been written by a medieval scribe, and she thought it might be important.
Rask opened the envelope in front of the PR team, expecting a legal filing or a subpoena. What he found instead was a single sheet of paper covered in dense Latin text, followed by a translation into modern Valdorian. The document was organized in a format Rask had not seen since his undergraduate studies in legal history: a Scholastic disputation, complete with objections, responses, and a formal determination.
He read the first line aloud, his voice flat and unreadable: "Utrum septem mortes in facilitatibus Solberg a Cardizine administratione causatae sint." Whether the seven deaths at Solberg facilities were caused by Cardizine administration.
He read the determination at the end, which concluded that the deaths could not have occurred naturally and that deliberate administration of Cardizine to patients with the CYP2C9 variant was the only logically possible explanation.
And then he read the final line, written in Latin at the bottom of the page: "Si hoc legere scis, nimium eruditionis habes." If you can read this, you know too much.
Rask set down the letter and stared at it for a long moment. The PR team watched him, waiting for an explanation. But Rask did not offer one. He stood up, walked to the window, and looked out at the rain falling over Kvelborg, his face as unreadable as the Latin text that lay on his desk like an indictment from another century.
"Cancel the rest of my meetings," he said. "And get me Torben Malling on the phone."
The PR team exchanged glances but did not argue. They filed out of the office, leaving Rask alone with the letter and the rain and the knowledge that somewhere out there, someone had found the pattern—and had understood it well enough to construct a proof that Rask, with all his legal training and all his corporate resources, could not refute.
The old knowledge, he thought, had found him at last. And it was not finished yet.
No comments yet. Be the first to comment!